Macitentan AccordPharma

ATC：C02KX04

治疗领域：Hypertension, Pulmonary

药理分类：Antihypertensives

修订号：1 · 最新影响 PI 的程序：VR/0000350552

适应症（原文）：AdultsMacitentan AccordPharma, as monotherapy or in combination, is indicated for the long-term treatmentof pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III (seesection 5.1)Paediatric populationMacitentan AccordPharma, as monotherapy or in combination, is indicated for the long-term treatmentof pulmonary arterial hypertension (PAH) in paediatric patients aged less than 18 years andbodyweight ≥ 40 kg with WHO Functional Class (FC) II to III (see section 5.1)